Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 1997
Multicenter randomized, controlled study of intramuscular administration of interferon-beta for the treatment of chronic hepatitis CA Castro, D Suárez, L Inglada, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)V Carreño, P Marcellin, S Hadziyannis, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.
Journal of Viral Hepatitis|October 10, 2012
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirinS Zeuzem, M Rodríguez-Torres, K Rajender Reddy, et al.
Journal of Viral Hepatitis|January 14, 2012
Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral responseA Craxi, S Koutsounas, P Ogurtsov, et al.
Journal of Viral Hepatitis|November 25, 2003
Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis CR Pérez, M Jiménez, J Crespo, et al.
Revista Espanola De Enfermedades Digestivas|January 23, 2009
[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry]M García-Cortés, Y Borraz, M I Lucena, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2016
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitisE Vilar-Gomez, L Calzadilla-Bertot, S L Friedman, et al.
Gut|November 28, 2006
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis BF Bonino, P Marcellin, G K K Lau, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2016
Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO)M Buti, J L Calleja, S Lens, et al.
Pageof 5